Continuous gradient elution chromatographic fractionation
US-2026085089-A1 · Mar 26, 2026 · US
This page is not indexed by search engines while we improve data quality.
Scheps Daniel patents
Scheps Daniel is listed as an inventor on 17 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Scheps Daniel |
| Total patents | 17 |
| First publication | Jun 16, 2016 |
| Latest publication | Mar 26, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Recombinant botulinum toxin with increased duration of effect
US-11952601-B2 · Apr 9, 2024 · US
A method of forming a conjugate of a sulfonamide and a polypeptide
US-2023346949-A1 · Nov 2, 2023 · US
Recombinant clostridial neurotoxins with increased duration of effect
US-11357821-B2 · Jun 14, 2022 · US
Novel recombinant botulinum neurotoxins with increased duration of effect
US-2022010294-A1 · Jan 13, 2022 · US
Recombinant botulinum neurotoxins with increased duration of effect
US-11155802-B2 · Oct 26, 2021 · US
Recombinant clostridial neurotoxins with increased duration of effect
US-11078472-B2 · Aug 3, 2021 · US
Novel recombinant botulinum neurotoxins with increased duration of effect
US-2021008156-A1 · Jan 14, 2021 · US
Novel recombinant botulinum toxin with increased duration of effect
US-2020354706-A1 · Nov 12, 2020 · US
Novel recombinant botulinum neurotoxins with increased duration of effect
US-2020131494-A1 · Apr 30, 2020 · US
Recent patents
Latest publications not already listed above.
Novel recombinant clostridial neurotoxins with increased duration of effect
US-2020129587-A1 · Apr 30, 2020 · US
Recombinant clostridial neurotoxins with increased duration of effect
US-10603353-B2 · Mar 31, 2020 · US
Novel recombinant botulinum toxin with increased duration of effect
US-2020048624-A1 · Feb 13, 2020 · US
Novel recombinant clostridial neurotoxins with increased duration of effect
US-2018327730-A1 · Nov 15, 2018 · US
Novel recombinant clostridial neurotoxins with increased duration of effect
US-2018169182-A1 · Jun 21, 2018 · US
Process for the Bioconversion of C3-C13 Alkanes to C3-C13 Primary Alcohols
US-2016201093-A1 · Jul 14, 2016 · US
Process for the Bioconversion of Butane to 1-Butanol
US-2016168597-A1 · Jun 16, 2016 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Merz Pharma Gmbh & Co Kgaa | 13 |
| Basf Se | 2 |
| Sanofi Sa | 1 |
| Sanofi Aventis Deutschland | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K14/33 | 13 |
| A61K38/00 | 13 |
| C12Y304/24069 | 12 |
| C12N9/52 | 8 |
| Y02A50/30 | 7 |